Answer
Emtricitabine (Emtriva) is licensed, in combination with other antiretroviral medicines, to treat HIV-1 infection in adults and children aged 4 months and over.
Sources for this answer
- Emtriva 200 mg hard capsulesGilead Sciences Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 31Document updated
Sources checked